Drugs / Piperacillin/tazobactam
last change Mar 2023 re-read 9 days ago

Piperacillin/tazobactam

Developed for
bacterial infectious disease
Investigated by
Sara Thønnings

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03108690 Oct 2017 → Mar 2023 bacterial infectious disease Sara Thønnings Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Piperacillin/tazobactam “Piperacillin/tazobactam” NCT03108690 ↗